In our previous work, we demonstrated that ExoGAG is efficient in the isolation of EVs from plasma samples of endometrial cancer patients and identified ANXA2 protein as a possible EV-based prognostic biomarker in liquid biopsy [33]. The gene discussed is ANXA2; the disease is endometrial cancer.